● Capacity: 2 hundred million vials/year of Xueshuantong for injection (lyophilized), 4 billion tablets/year, 600 million capsules/year, and 160 million cans/year of Guilinggao (turtle jelly), etc.

●  Owner: Nanning Zhongheng Investment Co., Ltd.

●  Construction site: Nanning, Guangxi, China

●Project Highlights: This project is a modern bio-pharmaceutical production base integrating the traditional Chinese medicine (TCM) industry, chemical pharmaceutical industry, bio-pharmaceutical industry, health food industry, a research and development (R&D) base, and pharmaceutical packaging material (glass vial) production. It is one of the largest domestic production bases for TCM injections used in the treatment of cardio-cerebrovascular diseases.